Cibus Announces Important Update to Rice Gene Editing Conversion Rates
Portfolio Pulse from
Cibus, Inc. (Nasdaq: CBUS) issued a correction regarding previously disclosed rice gene editing conversion rates, stating that the rates of 10-25% have not been reconfirmed due to high variability in data.
February 14, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cibus, Inc. corrected its previously disclosed rice gene editing conversion rates, indicating that the rates of 10-25% have not been reconfirmed due to high variability in data.
The correction of previously disclosed conversion rates suggests potential issues in the reliability of Cibus's gene editing technology for rice, which could negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100